ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 567,00
-0,86%
Dow Jones
40 211,72
0,00%
DAX
18 481,00
-0,64%
Brent Oil
83,02
-1,57%
Bitcoin
63 835,72
-1,57%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
08/12/201518h16Business WireTeva Announces Closing of Public Offerings of American Depositary Shares & Mandatory Convertible Preferred Shares in Connecti...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/12/201513h23Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/12/201513h00Business WireTeva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA™ (bendamustine hydrochloride) InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
03/12/201523h27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/12/201513h57Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/12/201504h35Business WireTeva Announces Pricing of Public Offerings of American Depositary Shares & Mandatory Convertible Preferred Shares in Connecti...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/12/201515h59Business WireTeva et Takeda établissent un partenariat unique afin de répondre aux exigences très diverses des patients et à l'utilisa...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/12/201510h41Business WireTeva und Takeda gründen einzigartige Partnerschaft: um den weitreichenden Patientenbedürfnissen und der wachsenden Bedeutun...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/12/201504h00The Motley FoolThere's a 0.0000000000028% Chance This Drug Doesn't WorkNYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201515h59The Motley FoolA $26 Billion Hedge Fund Just Bought 9 Million Shares of This Stock: Should You Follow?NYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201513h27Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201512h54Business WireTeva Announces Proposed Public Offerings of American Depositary Shares & Mandatory Convertible Preferred Shares in Connection...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201512h48Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)NYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201508h00Business WireTeva & Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients & Growing Importance of Generic Medicin...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/11/201508h00Business Wireテバ社と武田薬品による日本における合弁会社設立に関する基本合意契約締結についてNYSE:TEVATeva Pharmaceutical Industries Ltd
28/11/201513h40The Motley FoolAmgen Inc. Takes Aim at AbbVie Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
25/11/201509h00Business WireTeva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of MigraineNYSE:TEVATeva Pharmaceutical Industries Ltd
23/11/201513h50Dow Jones NewsPfizer and Allergan Strike Huge Inversion DealNYSE:TEVATeva Pharmaceutical Industries Ltd
23/11/201502h40Dow Jones NewsPfizer, Allergan Agree to MergeNYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201515h00Business WireTeva & University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative ...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201514h00Business WireTeva Reports Positive Top-Line Results from Phase III Trials Evaluating Fluticasone Propionate/Salmeterol & Fluticasone Propi...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201509h02Dow Jones NewsShares Of Deal Targets Reflect Regulatory FearNYSE:TEVATeva Pharmaceutical Industries Ltd
17/11/201514h04Business WireTeva to Present at the Jefferies Autumn 2015 Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
16/11/201513h41The Motley FoolBetter Dividend Stock: Gilead Sciences Inc. vs. Teva Pharmaceutical IndustriesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201513h20The Motley FoolGeneric Drugmakers Block Suitors, but Is That Good or Bad News?NYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201516h08Dow Jones NewsMylan Loses Hostile Bid for Perrigo--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201515h40Dow Jones NewsMylan Loses Hostile Bid for PerrigoNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201515h34Dow Jones NewsMylan Loses Hostile Bid for Perrigo--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201506h15Dow Jones NewsMylan Set to Lose in $26 Billion Hostile Takeover Battle for Perrigo -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
13/11/201505h20Dow Jones NewsMylan Set to Lose in $26 Billion Hostile Takeover Battle for PerrigoNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
PX4
SBF 120
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
CAP
Capgemini
EU
MC
Lvmh Moet Hennessy Louis...
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
EU
HO
Thales
EU
ML
Michelin
EU
DG
Vinci
USI
USTECH100
US Tech 100
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés